Global Surgeons Confront Heart Organ Scarcity as Mortality Rates Hit 15 Percent on Transplant Waitlists

Discover how global medical leaders at ISHLT 2026 are refining heart transplant allocation models to balance urgency and equity amid critical organ shortages.

By: AXL Media

Published: Apr 25, 2026, 11:25 AM EDT

Source: Information for this report was sourced from EurekAlert

The Moral Dilemma of Distributing a Critically Scarce Resource

The global medical community is currently grappling with a severe supply-and-demand crisis that leaves roughly 10 to 15 percent of heart transplant candidates to die before a donor organ becomes available. At the 46th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation, experts gathered in Toronto to dissect the diverse strategies nations use to manage this shortage. According to Guillaume Coutance, MD, a cardiologist at Georges Pompidou European Hospital, the primary limiting factor in saving lives is not surgical capability, but the sheer lack of donor organs, forcing every nation to balance the competing priorities of medical urgency, fairness, and the likelihood of long-term success.

Divergent Paths in Status and Score Based Allocation

In a comprehensive review of allocation schemes across 24 countries, researchers identified two primary philosophies governing who receives a transplant. The vast majority of nations, 23 in total, utilize status-based systems that prioritize patients based on the intensity of their current medical treatment, such as those relying on ECMO life-support machines. However, critics suggest these models might inadvertently reflect local clinical habits rather than true biological urgency. In contrast, France has pioneered a score-based system that uses complex statistical modeling to predict both the risk of death while waiting and the expected survival after the operation, attempting to remove subjectivity from the decision-making process.

The French Experiment with Data Driven Prioritization

France overhauled its national approach in 2018, moving away from urgency-based labels toward a composite scoring model that ranks every candidate in the country on a single, continuous scale. This four-step calculation integrates multiple variables, including kidney and liver function, biomarkers of heart failure, and the need for temporary mechanical support. According to Dr. Coutance, the model also accounts for geographic logistics and body size matching to ensure the organ reaches the most compatible recipient in the shortest time. By individualizing the process, the French system aims to standardize decisions and discourage the use of aggressive therapies that are sometimes applied solely to move a patient higher up...